Pallas Capital Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Buy |
103,241
+2,794
| +3% | +$101K | 0.14% | 120 |
|
|
2025
Q1 | $3.13M | Buy |
100,447
+8,113
| +9% | +$253K | 0.13% | 137 |
|
|
2024
Q4 | $2.36M | Buy |
+92,334
| New | +$2.36M | 0.1% | 147 |
|
|
2023
Q2 | – | Sell |
-20,982
| Closed | -$752K | – | 295 |
|
|
2023
Q1 | $752K | Sell |
20,982
-731
| -3% | -$26.2K | 0.07% | 163 |
|
|
2022
Q4 | $832K | Buy |
+21,713
| New | +$832K | 0.08% | 164 |
|